「norepinephrine」の共起表現一覧(1語右で並び替え)

norepinephrine

1語右で並び替え

該当件数:101件

  • acting as an inhibitor while dopamine and norepinephrine act as a stimulator of sexual desire.
  • oduced in the synthesis of dopa, dopamine, norepinephrine and epinephrine.
  • in, bufotenine, bufothionine, epinephrine, norepinephrine, and serotonin.
  • es, reduces levels of dopamine and cardiac norepinephrine, and inactivates tyrosine hydroxylase.
  • A deficiency of norepinephrine and epinephrine that causes orthostatic hy
  • take inhibitor of serotonin, dopamine, and norepinephrine, and also has some weak releasing activity
  • Two catecholamines, norepinephrine and dopamine, act as neuromodulators in th
  • n to inhibit the reuptake of serotonin and norepinephrine, and to possibly induce their release.
  • ne likely acts via inducing the release of norepinephrine and dopamine as with its analogues pemolin
  • transmitters (chemical nerve in the brain) norepinephrine and dopamine by blocking the action of the
  • levels, although thus possibly decreasing norepinephrine and epinephrine.
  • ransmitters that is membrane-bound, making norepinephrine and epinephrine the only transmitters synt
  • It increases serotonin, norepinephrine, and dopamine levels in the brain and is b
  • ansmitter systems and to block reuptake of norepinephrine and serotonin from the synapse, therefore
  • eased extracellular concentrations of both norepinephrine and dopamine and therefore an increase in
  • 2C receptor which normally acts to inhibit norepinephrine and dopamine release, thereby promoting ou
  • inhibitor of the reuptake of serotonin and norepinephrine and instead acts predominantly as a 5-HT2
  • s not induce the release of epinephrine or norepinephrine and instead acts as a selective β-adrenerg
  • ated to be a releasing agent of serotonin, norepinephrine and dopamine (with serotonin being the pri
  • hich are shared and sometimes contested by norepinephrine and GABA.
  • ity for the serotonin transporter over the norepinephrine and dopamine transporters, as transporter-
  • rmation of creatine, carnitine, DNA, tRNA, norepinephrine, and other compounds, it is transformed in
  • he production of neurotransmitters such as norepinephrine and serotonin, as well as supplementing wi
  • y have stronger effects on the reuptake of norepinephrine and/or serotonin than quinupramine itself.
  • e) are thought to stimulate the release of norepinephrine and/or dopamine from storage sites in nerv
  • as saturation of these receptors inhibits norepinephrine and/or dopamine release.
  • s most, including serotonin, dopamine, and norepinephrine, are absorbed from the synaptic cleft rath
  • neurotransmitters serotonin, dopamine and norepinephrine by interacting with the serotonin transpor
  • , adrenaline (epinephrine), noradrenaline ( norepinephrine), cortisol, and growth hormone.
  • Normetanephrine is a metabolite of norepinephrine created by action of catechol-O-methyl tra
  • Some people refer to this as norepinephrine deficiency.
  • Norepinephrine degradation.
  • tors triggers the release or inhibition of norepinephrine depending on species, presumably from the
  • The synthesis of norepinephrine depends on the presence of tyrosine, an am
  • It has been found to be effective when norepinephrine does not help.
  • esponding amines, for example epinephrine, norepinephrine, dopamine or serotonin.
  • ers, primarily glutamate, and also such as norepinephrine, dopamine, epinephrine, and serotonin, all
  • ous neurotransmitters including serotonin, norepinephrine, dopamine, GABA, and glutamate.
  • ally released epinephrine (adrenaline) and norepinephrine during periods of stress.
  • se of stored monoamines, such as dopamine, norepinephrine, epinephrine.
  • Norepinephrine) has a positive ionotropic effect on heart
  • In vertebrates, octopamine replaces norepinephrine in sympathetic neurons with chronic use of
  • It stimulates the release of norepinephrine in mammals, working as a stimulant.
  • h a variety of animals suggest the role of norepinephrine in olfactory learning, in which norepineph
  • stimulates the generation of serotonin and norepinephrine in the brain.
  • s and increases the levels of dopamine and norepinephrine in the brain through reuptake inhibition o
  • d is approximately 10x and 20x stronger on norepinephrine in comparison, respectively.
  • This effect is mediated by norepinephrine increasing the calcium uptake and therefor
  • glionic nerve cells, although they release norepinephrine into the blood.
  • renalase is expressed in heart muscle and norepinephrine is thought to aggravate heart attacks (myo
  • Norepinephrine is also released from postganglionic neuro
  • The catecholamine norepinephrine is a neuromodulator of the peripheral symp
  • Institute on Alcohol Abuse and Alcoholism, norepinephrine is secreted under stress, arousal, or thri
  • rane by the same mechanism that transports norepinephrine itself (NET, uptake 1), and uptake is esse
  • ually cause the degeneration of dopamine & norepinephrine levels in the brain, contributing to Parki
  • c catecholamine (dopamine, epinephrine and norepinephrine) levels.
  • research in the basic biology of dopamine, norepinephrine, opioid peptides in the brain, connections
  • rage in sympathetic neurons occurs via the norepinephrine pump; guanadrel slowly displaces norepinep
  • o effects on dopamine release and probably norepinephrine release as well, and as a 5-HT2A receptor
  • As an example, norepinephrine released from sympathetic neurons may inte
  • ne can essentially be considered selective norepinephrine releasing agents (NRAs).
  • Instead, it may act as a serotonin and/or norepinephrine releasing agent.
  • c effects, and instead acts as a selective norepinephrine releasing agent.
  • g the reuptake of serotonin, dopamine, and norepinephrine, respectively.
  • g the reuptake of serotonin, dopamine, and norepinephrine, respectively.
  • ne acts as a serotonin releasing agent and norepinephrine reuptake inhibitor.
  • Dibenzepin acts as a norepinephrine reuptake inhibitor, potent antihistamine,
  • It acts primarily as a norepinephrine reuptake inhibitor similarly to desipramin
  • It is known to act as a norepinephrine reuptake inhibitor, antihistamine, and ant
  • id agonist, serotonin releasing agent, and norepinephrine reuptake inhibitor.
  • It acts as a potent and highly selective norepinephrine reuptake inhibitor.
  • ns via the dopamine and noradrenaline (aka norepinephrine) reuptake transporters.
  • has desipramine-like effects, acting as a norepinephrine reuptake inhibitor without affecting the r
  • Dextroprotiline acts as a potent norepinephrine reuptake inhibitor and H1 receptor antagon
  • espite being a TCA, it acts as a selective norepinephrine reuptake inhibitor and has negligible affi
  • Talsupram (5-003) is a selective norepinephrine reuptake inhibitor (NRI) which was investi
  • Setiptiline acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor
  • eceptor antagonist, and weak serotonin and norepinephrine reuptake inhibitor.
  • pramine, it likely acts as a serotonin and norepinephrine reuptake inhibitor and serotonin, adrenena
  • o amitriptyline, acting as a serotonin and norepinephrine reuptake inhibitor, serotonin receptor ant
  • Main article: Norepinephrine reuptake inhibitor
  • e potently inhibits neuronal serotonin and norepinephrine reuptake, and it has been demonstrated tha
  • were shown to slow enzymatic breakdown of norepinephrine, serotonin and dopamine via inhibition of
  • thalamus, and has modest to no effects on norepinephrine, serotonin, dopamine, or glutamate levels
  • ture explains some of the clinical uses of norepinephrine, since a modification of the system affect
  • th serotonin (5-HT) and neurons containing norepinephrine that are targeted by the currently used an
  • For norepinephrine to be acted upon by PNMT in the cytosol, i
  • ce the release of serotonin, dopamine, and norepinephrine to varying extents.
  • to the presynaptic terminal transported by Norepinephrine transporter (NET).
  • It has been used to label the norepinephrine transporter in positron emission tomograph
  • ction of the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporte
  • as well: serotonin transporter (890 nM) > norepinephrine transporter (20,000) > dopamine transporte
  • "The involvement of the norepinephrine transporter (NET) in the pathophysiology a
  • AT), serotonin transporter (SERT), and the norepinephrine transporter (NET) in the outer cell membra
  • δ-opioid receptor, or for the serotonin or norepinephrine transporter.
  • t binding to the serotonin transporter and norepinephrine transporter.
  • sporter with increased selectivity for the norepinephrine transporters.
  • neurotransmitters/neuroregulators, such as norepinephrine, vasopressin, hypocretin (orexin), neurope
  • ed by AMPT may be mediated by decreases in norepinephrine, while changes in selective attention and
  • t the reuptake of serotonin, dopamine, and norepinephrine with IC50 values of 322 nM, 1,997 nM, and
  • Ca2+, ATP and catecholamines (epinephrine, norepinephrine) within the hormone storage vesicle core.